ROX Index Calculator

Clinical calculation support · Verify results before clinical use

Calculate oxygenation and respiratory effort

Enter SpO₂, FiO₂ as a percentage, and respiratory rate. Select the time since high-flow nasal cannula (HFNC) was started.

—ROX index

Measured pulse oximetry saturation, from 0 to 100.

Enter FiO₂ as a percentage; e.g. 40 means FiO₂ 0.40.

Use the current observed respiratory rate; it must be greater than zero.

Published failure-associated cutoffs differ by measurement time.

—ROX index
Result and contextual interpretation
Enter all values to calculate
ROX = (SpO₂ / FiO₂ fraction) / respiratory rate.
Clinical context

This index supports risk assessment in adults with acute hypoxemic respiratory failure receiving HFNC; it does not replace bedside assessment.

ROX is most directly supported in patients with pneumonia-related acute hypoxemic respiratory failure receiving HFNC. Interpret serial trends, work of breathing, oxygen requirement, haemodynamics, mental status, and the overall clinical trajectory. Do not delay escalation or intubation when clinically indicated.

About the ROX Index

The ROX index combines oxygenation and respiratory rate to help estimate the likelihood of HFNC success or failure in adults with acute hypoxemic respiratory failure. It is calculated as the ratio of SpO₂ to FiO₂, divided by respiratory rate.

ComponentInput formatRole in calculation
SpO₂Percent (0–100)Pulse oximetry oxygen saturation
FiO₂Percent (e.g. 40 means 0.40)Converted to a fraction before calculation
Respiratory rateBreaths/minDivisor in the index

Published reference thresholds

In cohorts of patients with pneumonia receiving HFNC, a ROX index ≥4.88 was associated with a lower risk of intubation at 2, 6, and 12 hours. Lower thresholds were identified as predictors of HFNC failure at specific timepoints:

Time after HFNC startFailure-associated thresholdInterpretation
2 hoursROX <2.85Associated with higher risk of HFNC failure
6 hoursROX <3.47Associated with higher risk of HFNC failure
12 hoursROX <3.85Associated with higher risk of HFNC failure
2, 6, or 12 hoursROX ≥4.88Associated with lower risk of intubation in the validation cohort

Values between the cited failure-associated threshold and 4.88 should not be treated as a definitive “safe” or “failure” zone. These thresholds are not universal rules and performance may vary by population and clinical context.

References

Roca O, Messika J, Caralt B, et al.Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index. Journal of Critical Care. 2016;35:200–205. DOI: 10.1016/j.jcrc.2016.05.022. PMID: 27481760.
Roca O, Caralt B, Messika J, et al.An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy. American Journal of Respiratory and Critical Care Medicine. 2019;199(11):1368–1376. DOI: 10.1164/rccm.201803-0589OC. PMID: 30576221.
Clinical disclaimer: This calculator is an educational and decision-support aid, not a substitute for clinical judgement. ROX should be interpreted alongside repeated bedside assessment and the patient’s full clinical picture. A low or worsening value should prompt clinical reassessment, but escalation decisions must not be based on this score alone.